Search alternatives:
mg decrease » a decrease (Expand Search), nn decrease (Expand Search), we decrease (Expand Search)
wt decrease » we decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
n decrease » nn decrease (Expand Search), a decrease (Expand Search), _ decreased (Expand Search)
_ decrease » _ decreased (Expand Search)
5 mg » 5 mm (Expand Search)
5 wt » _ wt (Expand Search), 5 ht (Expand Search)
mg decrease » a decrease (Expand Search), nn decrease (Expand Search), we decrease (Expand Search)
wt decrease » we decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
n decrease » nn decrease (Expand Search), a decrease (Expand Search), _ decreased (Expand Search)
_ decrease » _ decreased (Expand Search)
5 mg » 5 mm (Expand Search)
5 wt » _ wt (Expand Search), 5 ht (Expand Search)
-
1
-
2
-
3
-
4
-
5
-
6
Body and absolute and relative organ weights of rats post PM2.5 exposure (‾χ±s, n = 8).
Published 2025Subjects: -
7
-
8
-
9
-
10
The GluN2B-C456Y mutation decreases recombinant NMDAR currents and alters receptor properties.
Published 2020“…<i>n</i> = 4 oocytes for WT (pH IC<sub>50</sub> = 7.49 ± 0.016) and 5 oocytes for C456Y (pH IC<sub>50</sub> = 7.11 ± 0.0075), *<i>P</i> = 0.016, Mann-Whitney. …”
-
11
-
12
Olaparib reverses the oxLDL-mediated decrease in co-immunoprecipitation of IκBα with RelA or p50.
Published 2024“…Relative band densities from three independent experiments were analyzed. (A) OxLDL decreased co-immunoprecipitation of IκBα with both RelA and p50, and olaparib reversed the effect of oxLDL on the dissociation of IκBα with RelA and p50. …”
-
13
Scenario (6): Parameter variation (50% decrease)—With 5 N.m load applied at t = 0.3s.
Published 2023“…<p>Scenario (6): Parameter variation (50% decrease)—With 5 N.m load applied at t = 0.3s.…”
-
14
-
15
-
16
Hypothesis that explains and predicts expansion of ages of KD due to decreased IgG levels.
Published 2022Subjects: -
17
-
18
NatB inactivation decreased the level of MAPK and proposed model of EGFR/MAPK signaling regulation by NatB and the N-end rule pathways.
Published 2020“…<p>(A-B) <i>psid-D1</i> (A) or <i>psid-D4</i> (B) clones in 3rd instar fat body, which were marked by GFP expression (pointed by arrowheads), showed decreased MAPK levels (anti-MAPK staining, red). (C) <i>psid-D4</i> clones in wing disc, marked by GFP expression (pointed by arrowheads), showed decreased MAPK level. …”
-
19
FTY720 treatment decreased tumor growth in a xenograft model of hepatoblastoma.
Published 2019“…When tumors reached an average of 150 mm<sup>3</sup>, mice were randomized to receive vehicle (ORA-Plus, 50 μL, n = 7) or FTY720 (10 mg/kg body weight/day in ORA-Plus, 50 μL, n = 7) by oral gavage for 16 days. …”
-
20